This document discusses the history and production of the chemotherapy drug paclitaxel. It originally was derived from the bark of the Pacific yew tree, but harvesting the bark kills the tree. Alternative production methods were explored, including cell cultures of taxus plants and other plant species. Paclitaxel has a unique mechanism of action and showed promising results in cancer screening. It is now commonly produced through semi-synthesis from 10-deacetylbaccatin III which is extracted from the needles of various taxus species or produced by cell cultures.